(Q34432972)

2 August 2017

title

Less is more, regularly: metronomic dosing of cytotoxic drugs can target tumor angiogenesis in mice (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

D Hanahan

1

1 reference

2 August 2017

G Bergers

series ordinal

2

1 reference

2 August 2017

E Bergsland

series ordinal

3

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 April 2000

1 reference

Journal of Clinical Investigation

2 August 2017

published in

1 reference

2 August 2017

volume

105

1 reference

2 August 2017

issue

8

1 reference

2 August 2017

page(s)

1045-1047

1 reference

Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

Replication-selective adenoviruses as oncolytic agents

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

COX-2 inhibitors. A new class of antiangiogenic agents

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

6 July 2018

The Hallmarks of Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

Interferon-alpha-mediated down-regulation of angiogenesis-related genes and therapy of bladder cancer are dependent on optimization of biological dose and schedule.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

Safety and antitumor activity of recombinant soluble Apo2 ligand

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

Monoclonal antibodies targeting the VEGF receptor-2 (Flk1/KDR) as an anti-angiogenic therapeutic strategy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

Dose intensity for bolus versus infusion chemotherapy administration: review of the literature for 27 anti-neoplastic agents

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

Low-dose continuous intravenous infusion of 5-fluorouracil for metastatic breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

Potentiation of cytotoxic cancer therapies by TNP-470 alone and with other anti-angiogenic agents

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

Thalidomide is an inhibitor of angiogenesis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=300842

Long-term continuous 5-fluorouracil infusion in patients with advanced head and neck cancer

6 July 2018

1 reference

12 December 2020

Antiangiogenesis is produced by nontoxic doses of vinblastine

1 reference

12 December 2020

Inefficacy of low-dose continuous oral etoposide in non-small cell lung cancer

1 reference

12 December 2020

Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer

1 reference

12 December 2020

Weekly schedules of docetaxel

1 reference

12 December 2020

Identifiers

DOI

10.1172/JCI9872

1 reference

release_nd2tc6kryvg4tbogmvt3p6oooy

2 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/nd2tc6kryvg4tbogmvt3p6oooy

24 November 2022

mapped directly with Wikidata item

PMC publication ID

300842

1 reference

2 August 2017

1 reference